We are live on
!
Find out more
LC
Landaas & Company Portfolio holdings
AUM
$550M
1-Year Est. Return
22.32%
This Fund
S&P 500
This Quarter
Est. Return
+8.04%
1 Year Est. Return
+22.32%
3 Year Est. Return
+60.25%
5 Year Est. Return
+64.5%
10 Year Est. Return
–
AUM
$307M
AUM Growth
+$37.9M
(+14%)
Cap. Flow
+$16.5M
Cap. Flow
% of AUM
5.37%
Top 10 Holdings %
Top 10 Hldgs %
87.65%
Holding
90
New
11
Increased
37
Reduced
16
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$6.75M |
| 2 |
GARP
iShares MSCI USA Quality GARP ETF
GARP
|
+$2.79M |
| 3 |
iShares Treasury Floating Rate Bond ETF
TFLO
|
+$2.18M |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
+$1.14M |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
+$989K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Willis Towers Watson
WTW
|
+$268K |
| 2 |
iShares US Real Estate ETF
IYR
|
+$222K |
| 3 |
Nike
NKE
|
+$213K |
| 4 |
Lyft
LYFT
|
+$153K |
| 5 |
AbbVie
ABBV
|
+$153K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.32% |
| 2 | Consumer Discretionary | 1.65% |
| 3 | Financials | 1.08% |
| 4 | Healthcare | 1.02% |
| 5 | Consumer Staples | 0.94% |
Similar funds
ALA
TCM
BCM
RW
LWP
AI
AMG
WCP
Landaas & Company's Q1 2024 Portfolio in Review
As of Q1 2024, Landaas & Company held 90 positions worth $307M, up 14% from $270M the previous quarter. Its ten largest holdings account for 88% of the portfolio.
Landaas & Company deployed $16.5M of net new capital in Q1 2024, opening 11 new positions and adding to 37 existing holdings. Its largest new stake was Pinstripes Holdings, Inc.: 88,595 shares worth $288K.
By sector, the portfolio is most concentrated in Technology at 4.3% of assets, down from 4.7% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was AbbVie, an estimated $153K trimmed.
- Landaas & Company's largest Q1 2024 buy was Pinstripes Holdings, Inc.: 88,595 shares worth $288K.
- Landaas & Company added most to iShares MSCI USA Quality Factor ETF in Q1 2024, an estimated $6.75M increase.
- Landaas & Company's biggest Q1 2024 reduction was AbbVie, cutting an estimated $153K.
- Landaas & Company fully exited Willis Towers Watson in Q1 2024, selling an estimated $268K.
- Landaas & Company's ten largest holdings make up 88% of its $307M portfolio in Q1 2024.
- Landaas & Company opened 11 new positions and closed 4 in Q1 2024.
- Landaas & Company's portfolio value rose 14% quarter-over-quarter to $307M.
Based on Landaas & Company's 13F filing for Q1 2024, filed 9 May 2024.